United States · FDA National Drug Code directory
SOGROYA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-2035_02935ecf-5395-4b9b-9b2f-75d59ca651f3
- Product NDC
- 0169-2035
- Form
- INJECTION, SOLUTION
- Composition / generic term
- somapacitan-beco
- Labeler
- Novo Nordisk
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230501
- Source listing expiry
- 20271231
Source-listed ingredients
- SOMAPACITAN — 3.3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, PLASTIC in 1 CARTON (0169-2035-11) / 1.5 mL in 1 SYRINGE, PLASTIC · 0169-2035-11
- 1 SYRINGE, PLASTIC in 1 CARTON (0169-2035-90) / 1.5 mL in 1 SYRINGE, PLASTIC · 0169-2035-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →